Searcy Financial Services Inc Vertex Pharmaceuticals Inc Transaction History

Searcy Financial Services Inc

  • $211 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021
SELL
$207.01 - $276.09 $4.34 Million - $5.79 Million
-20,984 Closed
0 $0
Q3 2020

Oct 16, 2020
BUY
$255.65 - $303.1 $468,350 - $555,279
1,832 Added 9.57%
20,984 $5.71 Million
Q2 2020

Aug 04, 2020
BUY
$225.48 - $295.8 $4.32 Million - $5.67 Million
19,152 New
19,152 $5.56 Million

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Searcy Financial Services Inc Portfolio

Follow Searcy Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Searcy Financial Services Inc , based on Form 13F filings with the SEC.

News

Stay updated on Searcy Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email